New imaging technology reveals previously unseen immune cell patterns in tissue
Scientists can now see a previously hidden dimension of the immune system thanks to BCR-MERFISH, a new imaging technology developed by researchers at Boston Children's Hospital. By mapping where different groups of antibody-producing cells are located in tissue, the technology could help researchers better understand how immune responses contribute to disease and eventually inform new approaches…
Researchers at Boston Children's Hospital have developed a new imaging technology called BCR-MERFISH that allows scientists to visualize previously unknown patterns of immune cells within tissue. By mapping the locations of various groups of antibody-producing plasma cells, BCR-MERFISH could lead to better understanding of immune responses in disease and potentially inform new diagnostic and treatment approaches.
Jeffrey R. Moffitt, senior author of the study published in Nature Methods, explained that the technology reveals spatial organization of the adaptive immune system in tissues that was previously undetectable. Plasma cells, which produce antibodies to recognize and fight threats, can look identical under a microscope but actually produce antibodies that target different things.
BCR-MERFISH builds upon MERFISH technology, which uses microscopy to measure RNA and reveal active genes in cells. By adapting MERFISH to distinguish plasma cell groups based on specific antibody receptor genes and measure gene activity in surrounding cells, researchers were able to identify 434 distinct plasma-cell groups in the intestines of mice, some of which formed unexpected clusters.
The maps showed that these clusters were not evenly distributed throughout the tissue. While the reasons for the clusters are unknown, they could provide insights into how antibody-producing cells behave at sites of inflammation and disease. For example, in inflammatory bowel diseases like Crohn's and ulcerative colitis, plasma cells tend to gather at affected intestinal sites.
The ability to connect immune-cell identity with precise location could help researchers understand immune activity in tumors, B-cell lymphomas and other conditions involving the adaptive immune system. The technology has also revealed that germ-free mice, raised without microbes, have fewer plasma cells and less diversity among identifiable groups.
Moffitt's lab is now studying human biopsy samples to explore potential clinical applications of BCR-MERFISH in understanding diseases of the intestine.
Rewritten by urgent.news; may contain errors — check the original.
Source: medicalxpress.com